Advertising

The Seattle Times Company

NWjobs | NWautos | NWhomes | NWsource | Free Classifieds | seattletimes.com

Business / Technology


Our network sites seattletimes.com | Advanced

Originally published November 12, 2009 at 7:10 AM | Page modified November 12, 2009 at 9:16 AM

Comments (0)     E-mail E-mail article      Print Print      Share Share

Abbott buys pain drug candidate for up to $190M

Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as $190 million.

The Associated Press

NORTH CHICAGO, Ill. —

Abbott Laboratories said Thursday it is buying a potential chronic pain drug from PanGenetics BV for as much as $190 million.

Abbott said the drug is in early-stage clinical testing as a treatment for pain cause by arthritis. If that trial is successful, Abbott may test it against chronic lower back pain, cancer pain, and diabetic nerve pain. It said the drug blocks a chemical called nerve growth factor, or NGF, which is released at sites where tissues are damaged or inflamed.

PanGenetics, based in the Netherlands, will receive $170 million upfront from Abbott, and $20 million in milestone payments if the drug advances through development. Abbott said the deal will close before the end of 2009, and while it will take one-time charges related to the deal, the company said it does not need to change its profit guidance for the year.

In morning trading, Abbott stock rose a penny to $53.27.

E-mail E-mail article      Print Print      Share Share

More Business & Technology

UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case

UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip

UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award

UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall

NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook

More Business & Technology headlines...

Comments
No comments have been posted to this article.

advertising


Get home delivery today!

Video

Advertising

AP Video

Entertainment | Top Video | World | Offbeat Video | Sci-Tech

Marketplace

Advertising